Efficacy and Side Effects of Narrowband-UVB in Early Stage Cutaneous T-Cell Lymphoma in Jordanian Patients

Table 3

𝑃 values comparing rates of complete remission, number of treatment sessions, and NB-UVB dose between skin types III, IV, and V.

	Rates of complete remission	Number of sessions	NB-UVB dose in J/cm^2
𝑃 value; (skin types III and IV)	0.031	0.027	0.043
𝑃 value; (skin types IV and V)	0.043	0.037	0.037
𝑃 value; (skin types III and V)	0.041	0.0073	0.0086